Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Cytomegalovirus (CMV) reactivation occurs when the virus, which has been dormant in the body after an initial infection, becomes active again. This typically happens when the immune system is weakened due to conditions like immunosuppression, organ transplantation, or certain medications.
This test measures the quantity of CMV IgM antibodies in the blood. The presence of IgM antibodies may indicate a reactivation of the dormant virus, particularly in individuals with compromised immune systems or those undergoing immunosuppressive therapy. This quantitative measurement helps healthcare providers assess the level of viral activity.
CMV reactivation can be challenging to identify based on symptoms alone, as they may be mild or overlap with other conditions. Blood testing for specific antibodies is essential to confirm whether the virus has reactivated and to guide appropriate treatment decisions.
CMV reactivation testing is particularly important for immunocompromised individuals, organ transplant recipients, people undergoing chemotherapy, or those with HIV/AIDS. These populations are at higher risk for reactivation and may experience more severe complications if the virus becomes active.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.